Literature DB >> 21775452

CD11c controls herpes simplex virus 1 responses to limit virus replication during primary infection.

Sariah J Allen1, Kevin R Mott, Aziz A Chentoufi, Lbachir BenMohamed, Steven L Wechsler, Christie M Ballantyne, Homayon Ghiasi.   

Abstract

CD11c is expressed on the surface of dendritic cells (DCs) and is one of the main markers for identification of DCs. DCs are the effectors of central innate immune responses, but they also affect acquired immune responses to infection. However, how DCs influence the efficacy of adaptive immunity is poorly understood. Here, we show that CD11c(+) DCs negatively orchestrate both adaptive and innate immunity against herpes simplex virus type 1 (HSV-1) ocular infection. The effectiveness and quantity of virus-specific CD8(+) T cell responses are increased in CD11c-deficient animals. In addition, the levels of CD83, CD11b, alpha interferon (IFN-α), and IFN-β, but not IFN-γ, were significantly increased in CD11c-deficient animals. Higher levels of IFN-α, IFN-β, and CD8(+) T cells in the CD11c-deficient mice may have contributed to lower virus replication in the eye and trigeminal ganglia (TG) during the early period of infection than in wild-type mice. However, the absence of CD11c did not influence survival, severity of eye disease, or latency. Our studies provide for the first time evidence that CD11c expression may abrogate the ability to reduce primary virus replication in the eye and TG via higher activities of type 1 interferon and CD8(+) T cell responses.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21775452      PMCID: PMC3196403          DOI: 10.1128/JVI.05208-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes.

Authors:  Huaizhu Wu; John R Rodgers; Xiao-Yuan Dai Perrard; Jerry L Perrard; Joseph E Prince; Yasunori Abe; Beckley K Davis; Greg Dietsch; C Wayne Smith; Christie M Ballantyne
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

Review 2.  Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells.

Authors:  N Novak; W M Peng
Journal:  Clin Exp Immunol       Date:  2005-12       Impact factor: 4.330

3.  CNI-1493 mediated suppression of dendritic cell activation in vitro and in vivo.

Authors:  Elisabeth Zinser; Nadine Turza; Alexander Steinkasserer
Journal:  Immunobiology       Date:  2004       Impact factor: 3.144

4.  Engagement of CD83 on B cells modulates B cell function in vivo.

Authors:  Birte Kretschmer; Katja Lüthje; Stefanie Schneider; Bernhard Fleischer; Minka Breloer
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

Review 5.  Ocular viral infections.

Authors:  D Pavan-Langston
Journal:  Med Clin North Am       Date:  1983-09       Impact factor: 5.456

6.  Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells.

Authors:  Lidija Bosnjak; Monica Miranda-Saksena; David M Koelle; Ross A Boadle; Cheryl A Jones; Anthony L Cunningham
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

7.  Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis.

Authors:  Evelyn A Kurt-Jones; Melvin Chan; Shenghua Zhou; Jennifer Wang; George Reed; Roderick Bronson; Michelle M Arnold; David M Knipe; Robert W Finberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-22       Impact factor: 11.205

8.  Oculogenital transmission of type 2 herpes simplex virus in adults.

Authors:  J O Oh; S J Kimura; H B Ostler; C R Dawson; G Smolin
Journal:  Surv Ophthalmol       Date:  1976 Sep-Oct       Impact factor: 6.048

Review 9.  Prospects for developing an effective vaccine against ocular herpes simplex virus infection.

Authors:  David M Koelle; Homayon Ghiasi
Journal:  Curr Eye Res       Date:  2005-11       Impact factor: 2.424

10.  Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo.

Authors:  D A Leib; T E Harrison; K M Laslo; M A Machalek; N J Moorman; H W Virgin
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  15 in total

1.  CD11a regulates effector CD8 T cell differentiation and central memory development in response to infection with Listeria monocytogenes.

Authors:  Tina O Bose; Quynh-Mai Pham; Evan R Jellison; Juliette Mouries; Christie M Ballantyne; Leo Lefrançois
Journal:  Infect Immun       Date:  2013-01-28       Impact factor: 3.441

2.  Temozolomide does not impair gene therapy-mediated antitumor immunity in syngeneic brain tumor models.

Authors:  Marianela Candolfi; Kader Yagiz; Mia Wibowo; Gabrielle E Ahlzadeh; Mariana Puntel; Homayon Ghiasi; Neha Kamran; Christopher Paran; Pedro R Lowenstein; Maria G Castro
Journal:  Clin Cancer Res       Date:  2014-02-05       Impact factor: 12.531

3.  Absence of Signal Peptide Peptidase, an Essential Herpes Simplex Virus 1 Glycoprotein K Binding Partner, Reduces Virus Infectivity In Vivo.

Authors:  Shaohui Wang; Homayon Ghiasi
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

4.  The herpes simplex virus type 1 latency-associated transcript inhibits phenotypic and functional maturation of dendritic cells.

Authors:  Aziz Alami Chentoufi; Xavier Dervillez; Gargi Dasgupta; Chelsea Nguyen; Khaled W Kabbara; Xianzhi Jiang; Anthony B Nesburn; Steven L Wechsler; Lbachir Benmohamed
Journal:  Viral Immunol       Date:  2012-04-18       Impact factor: 2.257

5.  Herpes Simplex Virus 1 Suppresses the Function of Lung Dendritic Cells via Caveolin-1.

Authors:  Bing Wu; Shuang Geng; Yanmin Bi; Hu Liu; Yanxin Hu; Xinqiang Li; Yizhi Zhang; Xiaoyu Zhou; Guoxing Zheng; Bin He; Bin Wang
Journal:  Clin Vaccine Immunol       Date:  2015-05-27

6.  The therapeutic effect of an autologous and allogenic mixed glioma cell lysate vaccine in a rat model.

Authors:  Haiping He; Yulin Cen; Ping Wang; Xu Zeng; Shan Zeng; Xinlong Li; Xiaofei Lu; Chuanhong Zhong; Yang Ming; Ligang Chen; Lilei Peng
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-06       Impact factor: 4.322

7.  The Herpes Simplex Virus Latency-Associated Transcript Gene Is Associated with a Broader Repertoire of Virus-Specific Exhausted CD8+ T Cells Retained within the Trigeminal Ganglia of Latently Infected HLA Transgenic Rabbits.

Authors:  Ruchi Srivastava; Xavier Dervillez; Arif A Khan; Aziz A Chentoufi; Sravya Chilukuri; Nora Shukr; Yasmin Fazli; Nicolas N Ong; Rasha E Afifi; Nelson Osorio; Roger Geertsema; Anthony B Nesburn; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

Review 8.  Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknown.

Authors:  Aziz Alami Chentoufi; Elizabeth Kritzer; David M Yu; Anthony B Nesburn; Lbachir Benmohamed
Journal:  Clin Dev Immunol       Date:  2012-03-26

Review 9.  Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.

Authors:  Aziz Alami Chentoufi; Lbachir Benmohamed
Journal:  Clin Dev Immunol       Date:  2012-12-24

10.  A Dual Role for Corneal Dendritic Cells in Herpes Simplex Keratitis: Local Suppression of Corneal Damage and Promotion of Systemic Viral Dissemination.

Authors:  Kai Hu; Deshea L Harris; Takefumi Yamaguchi; Ulrich H von Andrian; Pedram Hamrah
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.